Emcure Pharmaceuticals Q1 Results
- BSE: 544210
- NSE: EMCURE
- ISIN: INE168P01015
- Sector: -
BSE
1,310.10
-14.20 (-1.07%)
-14.20 (-1.07%)Volume5.89 K
Updated: Fri 20 Jun, 2025 | 15:29:01
NSE
1,312.40-13.10 (-0.99%)
-13.10 (-0.99%)Volume2.46 L
Updated: Fri 20 Jun, 2025 | 15:54:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Emcure Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,815.14 | 2,116.25 | 2.47% | 1,815.14 | N/A |
| Selling/ General/ Admin Expenses Total | 350.40 | 373.37 | 3.51% | 350.40 | N/A |
| Depreciation/ Amortization | 93.59 | 96.84 | 3.34% | 93.59 | N/A |
| Other Operating Expenses Total | 445.32 | 460.85 | -1.15% | 445.32 | N/A |
| Total Operating Expense | 1,572.41 | 1,833.54 | 1.40% | 1,572.41 | N/A |
| Operating Income | 242.73 | 282.71 | 10.00% | 242.73 | N/A |
| Net Income Before Taxes | 207.41 | 260.61 | 24.27% | 207.41 | N/A |
| Net Income | 144.08 | 188.96 | 25.11% | 144.08 | N/A |
| Diluted Normalized EPS | 7.95 | 10.38 | 47.51% | 7.95 | N/A |